AI assistant
Sending…
ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2025
Oct 4, 2025
33148_dirs_2025-10-03_8c2a2844-c6ab-4152-ac96-909879072cb9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2025-09-24
Reporting Person: Fong Peter (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-24 | Common Stock | A | 23333 | — | Acquired | 23333 | Direct |
| 2025-09-24 | Common Stock | A | 30000 | — | Acquired | 53333 | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on September 24, 2026.
F2: Represents RSUs that will vest in equal monthly installments over a three-year period following September 23, 2025.
More from ROCKET PHARMACEUTICALS, INC.
Merger & Acquisition
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Feb 20